D

Ginkgo Bioworks Holdings
D

DNA

10.810
USD
-0.61
(-5.34%)
مغلق
حجم التداول
63,752
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
621,346,963
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    A
    -1.400
    (-1.02%)
    135.400 USD
    B
    BGI
    0.02000
    (1.69%)
    1.20000 USD
    C
    C
    -1.700
    (-2.09%)
    79.670 USD
    D
    D
    1.080
    (1.92%)
    57.420 USD
    X
    X
    -0.970
    (-2.56%)
    36.960 USD
    Z
    Z
    -3.425
    (-4.37%)
    74.900 USD
    المزيد
الأخبار
المقالات

العنوان: Ginkgo Bioworks Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.